{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:31:27Z","timestamp":1778232687568,"version":"3.51.4"},"reference-count":110,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012304","name":"School of Medicine, Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jid.2023.01.043","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:16:07Z","timestamp":1685200567000},"page":"1358-1368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-8631","authenticated-orcid":false,"given":"Steven D.","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-7120","authenticated-orcid":false,"given":"Frank","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-450X","authenticated-orcid":false,"given":"Ross L.","family":"Cagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8420-7831","authenticated-orcid":false,"given":"Annette","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7874-5585","authenticated-orcid":false,"given":"Verena","family":"Staedtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0494-2946","authenticated-orcid":false,"given":"Ina","family":"Ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-6730","authenticated-orcid":false,"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-8316","authenticated-orcid":false,"given":"Sang Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-7047","authenticated-orcid":false,"given":"Carlos G.","family":"Romo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-0993","authenticated-orcid":false,"given":"Jaishri O.","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5363-3053","authenticated-orcid":false,"given":"Kavita Y.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.01.043_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/neuonc\/noaa053","article-title":"Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions","volume":"22","author":"Akshintala","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jid.2023.01.043_bib2","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.febslet.2013.03.035","article-title":"Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes","volume":"587","author":"Arun","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jid.2023.01.043_bib4","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1158\/1078-0432.CCR-17-0270","article-title":"Transcriptional mechanisms of resistance to anti-PD-1 therapy","volume":"23","author":"Ascierto","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2023.01.043_bib5","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.01.043_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev.bi.56.070187.004023","article-title":"RAS genes","volume":"56","author":"Barbacid","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jid.2023.01.043_bib7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/gcc.20921","article-title":"Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors","volume":"50","author":"Beert","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/hmg\/ddv635","article-title":"Nf1+\/- monocytes\/macrophages induce neointima formation via CCR2 activation","volume":"25","author":"Bessler","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib9","first-page":"4682","article-title":"RAS oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.01.043_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cllc.2020.09.011","article-title":"Clinical characteristics, treatments, and concurrent mutations in non-small cell lung cancer patients with NF1 mutations","volume":"22","author":"Bowman","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15183-1","article-title":"The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation","volume":"7","author":"Brohl","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.01.043_bib12","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1038\/s41467-018-07452-y","article-title":"NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation","volume":"9","author":"Brosseau","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.01.043_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-020-01103-4","article-title":"Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing","volume":"9","author":"Brosseau","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jid.2023.01.043_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2011.08.008","article-title":"Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP\/PKA\/ROCK-dependent manner","volume":"49","author":"Brown","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jid.2023.01.043_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100044","article-title":"Insights into the pathogenesis of NF1-associated neoplasms","volume":"1","author":"Bui","year":"2021","journal-title":"JID Innov"},{"key":"10.1016\/j.jid.2023.01.043_bib16","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1158\/1535-7163.MCT-19-0123","article-title":"Ketotifen modulates mast cell chemotaxis to kit-ligand, but does not impact mast cell numbers, degranulation, or tumor behavior in neurofibromas of Nf1-deficient mice","volume":"18","author":"Burks","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2023.01.043_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13023-018-0772-z","article-title":"Cutaneous neurofibromas in neurofibromatosis type I: a quantitative natural history study","volume":"13","author":"Cannon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2023.01.043_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.1986.tb48061.x","article-title":"The genetic aspects of neurofibromatosis","volume":"486","author":"Carey","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jid.2023.01.043_bib19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/humu.23552","article-title":"Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: correlating histological and genomic findings","volume":"39","author":"Carri\u00f3","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jid.2023.01.043_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","article-title":"Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma","volume":"26","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2023.01.043_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-18-0151","article-title":"Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the hippo pathway","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2023.01.043_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng0995-90","article-title":"Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene","volume":"11","author":"Colman","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.01.043_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.01.043_bib25","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11064-011-0433-2","article-title":"Aberrant cAMP metabolism in NF1 malignant peripheral nerve sheath tumor cells","volume":"36","author":"Dang","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jid.2023.01.043_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.embor.7400602","article-title":"A\u00a0novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein","volume":"7","author":"D'Angelo","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jid.2023.01.043_bib27","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1523\/JNEUROSCI.23-26-08949.2003","article-title":"The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes","volume":"23","author":"Dasgupta","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jid.2023.01.043_bib28","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1523\/JNEUROSCI.4693-04.2005","article-title":"Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in\u00a0vitro and in\u00a0vivo","volume":"25","author":"Dasgupta","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jid.2023.01.043_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/0008-5472.236.65.1","article-title":"Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.01.043_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/aja.1001950307","article-title":"Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development","volume":"195","author":"Daston","year":"1992","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jid.2023.01.043_bib31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/gcc.20353","article-title":"Somatic loss of wild type NF1 allele in neurofibromas: comparison of NF1 microdeletion and non-microdeletion patients","volume":"45","author":"De Raedt","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib32","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.01.043_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1346-8138.14025","article-title":"Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1","volume":"45","author":"Ehara","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2023.01.043_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s005950300074","article-title":"Novel mutations of neurofibromatosis type 1 gene in small cell lung cancers","volume":"33","author":"Furukawa","year":"2003","journal-title":"Surg Today"},{"key":"10.1016\/j.jid.2023.01.043_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101224","article-title":"Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis","volume":"27","author":"Ghoshal","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.jid.2023.01.043_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13072-020-00380-6","article-title":"Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK\/p38 signaling","volume":"14","author":"Grit","year":"2021","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jid.2023.01.043_bib38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.01.043_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13023-019-1265-4","article-title":"Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey","volume":"14","author":"Guiraud","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2023.01.043_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/gcc.2870130206","article-title":"Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1","volume":"13","author":"Gutmann","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib41","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.61.10.1397","article-title":"Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1","volume":"61","author":"Gutmann","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2023.01.043_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s004390000374","article-title":"Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma","volume":"107","author":"Gutzmer","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrclinonc.2010.41","article-title":"The molecular pathology of cancer","volume":"7","author":"Harris","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2023.01.043_bib44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cell.2010.06.004","article-title":"NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome","volume":"142","author":"H\u00f6lzel","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.01.043_bib45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jmg.26.11.712","article-title":"A\u00a0genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling","volume":"26","author":"Huson","year":"1989","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.194.1.57","article-title":"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in\u00a0vivo and in\u00a0vitro","volume":"194","author":"Ingram","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2023.01.043_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.191.1.181","article-title":"Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in\u00a0vivo","volume":"191","author":"Ingram","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2023.01.043_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.onc.1202294","article-title":"Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors","volume":"18","author":"Iyengar","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2023.01.043_bib49","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1073\/pnas.90.12.5539","article-title":"Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP","volume":"90","author":"Johnson","year":"1993","journal-title":"Ras. Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2023.01.043_bib50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jid.2022.07.022","article-title":"Genomic and transcriptomic analyses of NF1-mutant melanoma identify potential targeted approach for treatment","volume":"143","author":"Jour","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.01.043_bib51","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.4049\/jimmunol.178.4.2527","article-title":"K-ras is critical for modulating multiple c-kit-mediated cellular functions in wild-type and Nf1+\/- mast cells","volume":"178","author":"Khalaf","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2023.01.043_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00690419","article-title":"The Ras signal transduction pathway","volume":"13","author":"Khosravi-Far","year":"1994","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jid.2023.01.043_bib53","article-title":"27.12 MHz radiofrequency ablation for benign cutaneous lesions","volume":"2016","author":"Kim","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jid.2023.01.043_bib54","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jnen\/60.9.917","article-title":"Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas","volume":"60","author":"Kluwe","year":"2001","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.jid.2023.01.043_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib56","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mc.20552","article-title":"Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase","volume":"48","author":"Kweh","year":"2009","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jid.2023.01.043_bib57","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","article-title":"Tumor microenvironment and neurofibromatosis type I: connecting the GAPs","volume":"26","author":"Le","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2023.01.043_bib58","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib59","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bjps.2007.03.035","article-title":"Electrosurgical excision technique for the treatment of multiple cutaneous lesions in neurofibromatosis type I","volume":"61","author":"Levine","year":"2008","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jid.2023.01.043_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-3806(01)00190-0","article-title":"Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons","volume":"130","author":"Li","year":"2001","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.jid.2023.01.043_bib61","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1172\/JCI99424","article-title":"Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis","volume":"128","author":"Liao","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.01.043_bib62","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1101\/gad.341222.120","article-title":"SPRED proteins and their roles in signal transduction, development, and malignancy","volume":"34","author":"Lorenzo","year":"2020","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2023.01.043_bib63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/pcmr.13058","article-title":"Landscape of mutations in early stage primary cutaneous melanoma: an InterMEL study","volume":"35","author":"Luo","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2023.01.043_bib64","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41594-021-00687-2","article-title":"The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1","volume":"28","author":"Lupton","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jid.2023.01.043_bib65","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bjps.2016.03.024","article-title":"The use of electrodessication in the treatment of cutaneous neurofibromatosis: A retrospective patient satisfaction outcome assessment","volume":"69","author":"Lutterodt","year":"2016","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jid.2023.01.043_bib66","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1182\/blood-2008-04-155085","article-title":"Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+\/- mast cells","volume":"112","author":"McDaniel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jid.2023.01.043_bib67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000368078","article-title":"Treatment of neurofibromas with a carbon dioxide laser: a retrospective cross-sectional study of 106 patients","volume":"230","author":"M\u00e9ni","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2023.01.043_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139807","article-title":"Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins","volume":"131","author":"Mo","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.01.043_bib69","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41388-021-02156-y","article-title":"Neurofibromin and suppression of tumorigenesis: beyond the GAP","volume":"41","author":"Mo","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2023.01.043_bib70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-021-04024-x","article-title":"The structure of neurofibromin isoform 2 reveals different functional states","volume":"599","author":"Naschberger","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.01.043_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1750-1172-7-75","article-title":"Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1","volume":"7","author":"Nguyen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2023.01.043_bib72","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/mp.2015.48","article-title":"HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1","volume":"20","author":"Omrani","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jid.2023.01.043_bib73","first-page":"i117","article-title":"Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass","volume":"2","author":"Ortonne","year":"2020","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jid.2023.01.043_bib74","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","article-title":"Cutaneous neurofibromas: current clinical and pathologic issues","volume":"91","author":"Ortonne","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2023.01.043_bib75","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","article-title":"Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases","volume":"140","author":"Page","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jid.2023.01.043_bib76","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-12-1972","article-title":"In\u00a0vivo regulation of TGF-beta by R-Ras2 revealed through loss of the rasgap protein NF1","volume":"72","author":"Patmore","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.01.043_bib77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.1986.tb48079.x","article-title":"Collagens in neurofibromas and neurofibroma cell cultures","volume":"486","author":"Peltonen","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jid.2023.01.043_bib78","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/neuonc\/noz028","article-title":"Low mutation burden and frequent loss of CDKN2A\/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas","volume":"21","author":"Pemov","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jid.2023.01.043_bib79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","article-title":"Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with Nf1 knockout in boundary cap cells","volume":"9","author":"Radomska","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2023.01.043_bib80","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A\u00a0RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib81","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/hmg\/ddz095","article-title":"Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation","volume":"28","author":"Rhodes","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib82","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ajmg.a.37045","article-title":"Ketotifen suppression of NF1 neurofibroma growth over 30 years","volume":"167","author":"Riccardi","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jid.2023.01.043_bib83","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2023.01.043_bib84","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1593\/neo.08784","article-title":"Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations","volume":"10","author":"Sangha","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.jid.2023.01.043_bib85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0996-110","article-title":"Identification of NF1 mutations in both alleles of a dermal neurofibroma","volume":"14","author":"Sawada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib86","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/515504","article-title":"Confirmation of a double-hit model for the NF1 gene in benign neurofibromas","volume":"61","author":"Serra","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib87","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib88","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0021-9258(17)49919-4","article-title":"Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer","volume":"295","author":"Sherekar","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2023.01.043_bib89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","article-title":"Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1","volume":"92","author":"Side","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jid.2023.01.043_bib90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/gcc.2870010107","article-title":"Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17","volume":"1","author":"Skuse","year":"1989","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MOH.0b013e328339511b","article-title":"Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells","volume":"17","author":"Staser","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jid.2023.01.043_bib92","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ijc.21248","article-title":"Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurofibroma","volume":"117","author":"Storlazzi","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2023.01.043_bib93","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1101\/gad.190876.112","article-title":"A\u00a0shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1","volume":"26","author":"Stowe","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2023.01.043_bib94","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamadermatol.2022.3083","article-title":"Neurofibromatosis Type 1 and risk of skin cancer","volume":"158","author":"Trinh","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.01.043_bib95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s004390050317","article-title":"Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene","volume":"99","author":"Upadhyaya","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib96","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis Type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2023.01.043_bib97","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.01.043_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jid.2023.01.043_bib99","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jid.2021.07.164","article-title":"Combined cyclin-dependent kinase inhibition overcomes MAPK\/extracellular signal-regulated kinase kinase inhibitor resistance in plexiform neurofibroma of neurofibromatosis Type I","volume":"142","author":"Wang","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.01.043_bib100","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1158\/0008-5472.CAN-09-3769","article-title":"Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1","volume":"70","author":"Warrington","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.01.043_bib101","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.0.CO;2-4","article-title":"Hyperactive Ras as a therapeutic target in neurofibromatosis type 1","volume":"89","author":"Weiss","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib102","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jmb.2006.11.055","article-title":"The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex","volume":"366","author":"Welti","year":"2007","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jid.2023.01.043_bib103","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0000000000000451","article-title":"NF1 mutations are common in desmoplastic melanoma","volume":"39","author":"Wiesner","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2023.01.043_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc3175","article-title":"Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis","volume":"6","author":"Wishart","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jid.2023.01.043_bib105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archderm.139.1.103","article-title":"Visibility of neurofibromatosis 1 and psychiatric morbidity","volume":"139","author":"Wolkenstein","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2023.01.043_bib106","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","article-title":"Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in Desert hedgehog-expressing cells","volume":"13","author":"Wu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2023.01.043_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107909","article-title":"Structural insights into the SPRED1-neurofibromin-KRAS complex and disruption of SPRED1-neurofibromin interaction by oncogenic EGFR","volume":"32","author":"Yan","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2023.01.043_bib108","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/hmg\/ddl165","article-title":"Nf1+\/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling","volume":"15","author":"Yang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.01.043_bib109","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/-- and c-kit-dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.01.043_bib110","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:32:02Z","timestamp":1758303122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23019851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":110,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022202X23019851"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.01.043","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}